Market Analysis: Global Heart Valve Devices Market

Global Heart Valve Devices Market is expected to rise from its initial estimated value of USD 6.45 billion in 2018 to a projected value of USD 15.41 billion by 2026, registering a CAGR of 11.50% in the forecast period of 2019-2026. This rise in market value can be attributed to growth in the levels of geriatric population and increasing prevalence of unhealthy lifestyle choices globally.

Market Definition: Global Heart Valve Devices Market

Heart valve devices can be termed as the heart valves that are used in the cardiovascular surgical procedures for the repair and replacement of worn out or damaged parts. These heart valves are used to keep the blood flowing throughout the body by pumping it and letting the blood flow in different directions.

Market Drivers:

Growing levels of innovations in technology resulting in advanced levels of product offerings has resulted in growth of demand for the product
Increasing incidences of heart diseases and cardiovascular disorders that have been a result of increase in obesity levels

Market Restraint:

Increasing levels of cost associated with the cardiovascular surgical procedure is expected to act as a restraint to the market growth

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-heart-valve-devices-market

Segmentation: Global Heart Valve Devices Market
By Usage
Heart Valve Repair
Surgical Heart Valve Repair
Percutaneous Balloon Valvuloplasty
Transcatheter Heart Valve Repair
Heart Valve Replacement
By Product Type
Mechanical Heart Valves
Aortic Valves
Mitral Valves
Trans-Catheter/Percutaneous Heart Valves
Aortic Valves
Mitral Valves
Pulmonary Valves
Tissue/Bio-Prosthetic Heart Valves
Aortic Valves
Mitral Valves
Pulmonary Valves
Tricuspid Valves
By End-User
Hospitals
Ambulatory Surgical Centers
By Geography
North America
US.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-heart-valve-devices-market

Key Developments in the Market:

In December 2018, Meril Life Sciences Pvt. Ltd. announced the launch of artificially manufactured aortic heart valves for patients reluctant to undergo open heart valve replacement surgery. The “Trans-Catheter Aortic Heart Valve Replacement (TAVR)” will be sold under the name of “Myval”.
In January 2018, LivaNova PLC announced that they had initiated the “BELIEVE” (Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic Valve Implant) study. The study is initiated to identify the incidences of leaflet motion through CT imaging for the patients using LivaNova bioprosthetic aortic heart valve.
In January 2017, Abbott announced that they had completed the acquisition of St. Jude Medical, Inc. This acquisition will help in establishing Abbott as a major leader for the provision of medical devices and expanding their product portfolios significantly.
Competitive Analysis: Global Heart Valve Devices Market

Global heart valve devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of heart valve devices market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.